Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 25, 2004New England Journal of MedicineOpen Access

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

Bruce E. Sands
Bruce E. SandsStatens Serum InstitutFAFrank AndersonAgency for Science, Technology and ResearchÇBÇharles N. BernsteinUniversity of Notre Dame

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sands et al. (2004) studied this question.

synapsesocial.com/papers/69d8ace78c03fbaff8befde0https://doi.org/10.1056/nejmoa030815
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Azathioprine and 6-Mercaptopurine in Crohn Disease1995 · 956 citations
  2. 2Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent2001 · 3,730 citations
  3. 3Effect of Fecal Diversion Alone on Perianal Crohn's Disease2000 · 167 citations